InvestorsHub Logo
Followers 26
Posts 2016
Boards Moderated 0
Alias Born 01/11/2012

Re: north40000 post# 309392

Monday, 08/21/2017 4:41:32 PM

Monday, August 21, 2017 4:41:32 PM

Post# of 346385

I was beginning to look for Dr. Stopeck's breast cancer trials. Ronin et al have termed BC trials as "similarly disappointing", per hutschi's quote in #309329. I remember Dr. Stopeck's trials with a Bavi combo in breast cancer as not disappointing



Hey N4k, I can help. Check beside the one-time Ebola PR that came out just prior to the ASM a few years back. If it's not there you can most certainly find it near PPHM announcing failure in pancreatic the day of Russell buy-in that would have otherwise propelled the share price. If you still can't find it I'm certain it would be on slide #28 that Steve King presented to ASM attendees where we had all these milestones that would certainly increase shareholder value (we were at $1.50 pre-split on that day). Just off the top of my head, in case those are difficult to research, you can check the quarterly conference call where we were assure partnerships would be brought to fruition over the coming year back in 2014. I would stop there though, as I don't recall them mentioning anything recently except for all their attempts at avoiding the RS. Come to think of it though, perhaps they were under a gag order since this team was being sued for defrauding shareholders and corporate malfeasance.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News